Table 2.
Frequency (N) and Percentage (%) of Comorbidities in AYA HOPE Participants, by Comorbidity Index
| Comorbidity Index | ||||||
|---|---|---|---|---|---|---|
| AYA HOPE | Charlson | NCI | ||||
| N | % | N | % | N | % | |
| Comorbidity Categories | ||||||
| Cardiovascular | 30 | 6.2 | 12 | 2.5 | ^ | ^ |
| Diabetes | 18 | 3.7 | 18 | 3.7 | 18 | 3.7 |
| Endocrine | 10 | 2.1 | ^ | ^ | - | - |
| Gastrointestinal | 20 | 4.1 | 6 | 1.2 | 5 | 1.0 |
| HIV/AIDS | 18 | 3.7 | 18 | 3.7 | 18 | 3.7 |
| Hypertension | 29 | 6.0 | 29 | 6.0 | - | - |
| Liver | 13 | 2.7 | 13 | 2.7 | 13 | 2.7 |
| Mental Health | 40 | 8.2 | - | - | - | - |
| Neurological | 42 | 8.7 | ^ | ^ | ^ | ^ |
| Obesity / Overweight | 28 | 5.8 | - | - | - | - |
| Renal | 5 | 1.0 | ^ | ^ | ^ | ^ |
| Asthma / Respiratory | 30 | 6.1 | 30 | 6.1 | 30 | 6.1 |
| Rhematologic / Autoimmune | 5 | 1.0 | 5 | 1.0 | 5 | 1.0 |
| Hematologic | ^ | ^ | - | - | - | - |
| Distribution of Number of Comorbidities | ||||||
| 0 | 320 | 66.4 | 381 | 78.6 | 406 | 83.7 |
| 1 | 94 | 19.4 | 80 | 16.5 | 66 | 13.6 |
| ≥2 | 71 | 14.6 | 24 | 4.9 | 13 | 2.7 |
All indices are show unweighted for accurate frequency comparisons
- : The index does not include this comorbid condition
^
: Suppressed due to fewer than 5 cases with this comorbid condition